Albeit different in terms of incidence in specific organs, all forms of HHT rely on mutations affecting genes associated with the BMP/TGF-β pathway, and recent findings regarding DROSHA indicate that non-classical BMP/TGF-β pathways are also involved (Letteboer et al., 2006). This evidence concerns the gene TGFB1 and hereditary hemorrhagic telangiectasia.